<div class="container">

<table style="width: 100%;"><tr>
<td>drugprice</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>
Price of drugs under generic and brand names
</h2>

<h3>Description</h3>

<p>Across-countries median of median price ratio (MPR) of some medicines available in the private market under the generic name and the brand name of the originator (Gelders et al., 2005).
</p>


<h3>Usage</h3>

<pre><code class="language-R">data(drugprice)</code></pre>


<h3>Format</h3>

<p>A data frame with 13 observations on the following 2 variables.
</p>

<dl>
<dt><code>Drug</code></dt>
<dd>
<p>Generic name of drug, a character vector</p>
</dd>
<dt><code>Quantity</code></dt>
<dd>
<p>Unit for price computation, a character vector</p>
</dd>
<dt><code>OriginatorMPR</code></dt>
<dd>
<p>Originator median price ratio, a numeric vector</p>
</dd>
<dt><code>GenericMPR</code></dt>
<dd>
<p>Generic median price ratio, a numeric vector</p>
</dd>
</dl>
<h3>Details</h3>

<p>The data comes from a World Health Organization (WHO) commissioned study on variation of drug prices over a number of developing countries. For comparability, the price in a particular region is expressed as a ratio (called median price ratio or MPR) with respect to the organization's drug price indicator median values. The data reflect the across-country median of these ratios in respect of 13 medicines, most of which are in the WHO list of essential medicines.
</p>


<h3>Source</h3>

<p>Gelders, S., Ewen, M., Noguchi, N. and Laing R. (2005). Price, Availability and Affordability: An International Comparison of Chronic Disease Medicines, Background report prepared for the WHO Planning Meeting on the Global Initiative for Treatment of Chronic Diseases, Cairo, December 2005.
</p>


<h3>Examples</h3>

<pre><code class="language-R">data(drugprice)
head(drugprice)
</code></pre>


</div>